Prometheus Biosciences, Inc., A Subsidiary Of Merck & Co., Inc. (rahway, New Jersey Usa)

This study is testing whether an experimental drug called tulisokibart (MK-7240/PRA023) is safe and can help slow the decline of lung function in people with scleroderma who also have lung scarring (interstitial lung disease). The trial involves 154 participants who will receive …